Silence Therapeutics PLC (SLN) — Net Asset Quality Index
Silence Therapeutics PLC (SLN) has a Net Asset Quality Index of 36.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $106.41 Million minus total liabilities of $67.94 Million yields net assets of $38.47 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read SLN current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Silence Therapeutics PLC Net Asset Quality Index Over Time (1995–2025)
This chart shows how Silence Therapeutics PLC's Net Asset Quality Index has evolved across 31 annual periods from 1995 to 2025. As of June 2026, the index stands at 36.2%, representing net assets of $38.47 Million against total assets of $106.41 Million USD. For live market cap and overall valuation, see Silence Therapeutics PLC market capitalisation.
Annual Net Asset Quality Index for Silence Therapeutics PLC (1995–2025)
The table below presents the year-by-year Net Asset Quality Index for Silence Therapeutics PLC from 1995 to 2025, covering 31 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Silence Therapeutics PLC (SLN) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 47.4% | $62.30 Million | $131.44 Million | $69.14 Million | ▼ -18.7 pp |
| 2024 | 66.1% | $107.05 Million | $161.85 Million | $54.80 Million | ▲ +47.7 pp |
| 2023 | 18.4% | $17.40 Million | $94.53 Million | $77.12 Million | ▼ -2.1 pp |
| 2022 | 20.5% | $22.07 Million | $107.50 Million | $85.43 Million | ▲ +11.7 pp |
| 2021 | 8.9% | $8.53 Million | $96.19 Million | $87.67 Million | ▼ -1.7 pp |
| 2020 | 10.5% | $9.06 Million | $85.97 Million | $76.91 Million | ▼ -34.8 pp |
| 2019 | 45.4% | $20.91 Million | $46.08 Million | $25.17 Million | ▼ -44.8 pp |
| 2018 | 90.2% | $35.05 Million | $38.88 Million | $3.83 Million | ▼ -5.0 pp |
| 2017 | 95.2% | $52.35 Million | $55.01 Million | $2.66 Million | ▼ -1.9 pp |
| 2016 | 97.1% | $54.18 Million | $55.79 Million | $1.61 Million | ▼ -1.1 pp |
| 2015 | 98.2% | $60.43 Million | $61.55 Million | $1.12 Million | ▲ +4.9 pp |
| 2014 | 93.2% | $27.76 Million | $29.77 Million | $2.01 Million | ▼ -0.9 pp |
| 2013 | 94.1% | $27.58 Million | $29.30 Million | $1.72 Million | ▼ -0.3 pp |
| 2012 | 94.4% | $16.12 Million | $17.07 Million | $959.00K | ▼ -1.8 pp |
| 2011 | 96.2% | $32.18 Million | $33.44 Million | $1.26 Million | ▲ +1.2 pp |
| 2010 | 95.0% | $32.27 Million | $33.96 Million | $1.69 Million | ▲ +14.2 pp |
| 2009 | 80.9% | $8.89 Million | $10.99 Million | $2.10 Million | ▼ -12.6 pp |
| 2008 | 93.5% | $13.44 Million | $14.38 Million | $935.00K | ▲ +2.7 pp |
| 2007 | 90.7% | $17.68 Million | $19.48 Million | $1.80 Million | ▼ -3.0 pp |
| 2006 | 93.8% | $15.71 Million | $16.75 Million | $1.04 Million | ▲ +2.4 pp |
| 2005 | 91.4% | $15.69 Million | $17.17 Million | $1.49 Million | ▲ +17.9 pp |
| 2004 | 73.5% | $2.34 Million | $3.19 Million | $846.00K | ▼ -6.4 pp |
| 2003 | 79.9% | $5.18 Million | $6.49 Million | $1.31 Million | ▼ -8.0 pp |
| 2002 | 87.9% | $7.46 Million | $8.49 Million | $1.03 Million | ▼ -4.6 pp |
| 2001 | 92.5% | $8.95 Million | $9.67 Million | $725.00K | ▲ +0.5 pp |
| 2000 | 92.0% | $11.14 Million | $12.10 Million | $964.00K | ▲ +6.9 pp |
| 1999 | 85.2% | $9.21 Million | $10.81 Million | $1.60 Million | ▲ +0.4 pp |
| 1998 | 84.7% | $3.34 Million | $3.95 Million | $603.00K | ▼ -3.1 pp |
| 1997 | 87.9% | $4.63 Million | $5.27 Million | $640.00K | ▼ -6.0 pp |
| 1996 | 93.9% | $6.39 Million | $6.81 Million | $417.00K | ▲ +3.7 pp |
| 1995 | 90.2% | $2.76 Million | $3.06 Million | $301.00K | — |